Trajectories of antipsychotic response in drug-naive schizophrenia patients: results from the 6-month ESPASS follow-up study.
about
Clinical predictors of therapeutic response to antipsychotics in schizophreniaTreatment response, safety, and tolerability of paliperidone extended release treatment in patients recently diagnosed with schizophreniaThinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia.Factors associated with early response to olanzapine and clinical and functional outcomes of early responders treated for schizophrenia in the People's Republic of China.Early response or nonresponse at week 2 and week 3 predict ultimate response or nonresponse in adolescents with schizophrenia treated with olanzapine: results from a 6-week randomized, placebo-controlled trial.
P2860
Trajectories of antipsychotic response in drug-naive schizophrenia patients: results from the 6-month ESPASS follow-up study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Trajectories of antipsychotic ...... -month ESPASS follow-up study.
@en
Trajectories of antipsychotic ...... -month ESPASS follow-up study.
@nl
type
label
Trajectories of antipsychotic ...... -month ESPASS follow-up study.
@en
Trajectories of antipsychotic ...... -month ESPASS follow-up study.
@nl
prefLabel
Trajectories of antipsychotic ...... -month ESPASS follow-up study.
@en
Trajectories of antipsychotic ...... -month ESPASS follow-up study.
@nl
P2093
P2860
P356
P1476
Trajectories of antipsychotic ...... -month ESPASS follow-up study.
@en
P2093
P2860
P304
P356
10.1111/ACPS.12135
P407
P577
2013-04-18T00:00:00Z